Unfabled, a marketplace startup dedicated to women’s health and wellbeing, has secured $1.6 million in funding, raising its total funding to $2 million. The investment aims to fuel the growth of Unfabled’s consumer platform, data science capabilities, and B2B channel. The B2B aspect of Unfabled, a market intelligence platform, delivers crucial insights into consumer behavior, helping healthcare businesses in advancing women’s health.
Founded in 2021 by Hannah Samano, formerly of Unilever and Kasha, Unfabled offers a data-driven health platform that provides curated and personalized solutions for women. Users answer questions about their health priorities, receiving a selection of effective products tailored to their needs. According to the company, the platform has already attracted over 300,000 users seeking treatments for various conditions, from menstrual cramps to menopause.
The seed funding round saw contributions from Morgan Stanley, Exceptional Ventures, Atomico Angels, Founders Factory, Chai Ventures, SyndicateRoom, and 3 Sisters Ventures. Significant participation also came from angel investors, predominantly women from technology and healthcare sectors, including Maya Ghosn (Sequoia scout), Shefali Roy (former Apple and TrueLayer executive), Elaine Groenestein (early investor in Elvie), and Fiona Pathiraja (healthcare investor and philanthropist).
“Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause”, says Hannah Samano, Founder and CEO of Unfabled. “A major cause of the gender health gap is the lack of sex-aggregated data which causes a lack of insight and understanding across women’s health. We’re building the most user-friendly platform possible while also filling the massive gap that continues to exist in health-related data. The more we understand about female health, the more laser-focused we can become on improving it.”
Sanghamitra Karra, Managing Director and EMEA Head of the Morgan Stanley Inclusive Ventures Group, comments: “We have been impressed both by Unfabled’s platform and their reach, partnering with leading brands in the space. With an engaged community of 50,000 women and educational content on women’s health reaching 40M+ views, Hannah and the team’s proven organic-driven approach has enabled Unfabled to grow impressively since 2021.”
Matt Cooper, Co-Founder and Executive Chairman at Exceptional Ventures, adds: “When investing in a company, our primary focus is finding businesses that match our vision of helping people to live happier, healthier and longer lives. At the same time, we’re looking for the most talented entrepreneurs capable of delivering on that vision. Unfabled was a clear fit on both points, we were instantly taken by its mission to support women’s hormonal health. Unabled’s data-led platform empowers women to discover products and services often overlooked by mainstream healthcare and provides a consumer-friendly solution to a long-standing problem that affects so many lives. Hannah is a brilliant founder whose intellect, passion and drive for her business and its mission were irresistible.”
The fresh funds will be used to expand the consumer-facing platform as well as develop Unfabled’s in-house data science, a core element of its B2B offering.
